Cornerstone Capital Management Holdings LLC. bought a new position in shares of Iqvia Holdings Inc (NYSE:IQV) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 375,261 shares of the medical research company’s stock, valued at approximately $36,736,000. Cornerstone Capital Management Holdings LLC. owned about 0.18% of Iqvia as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Winslow Evans & Crocker Inc. acquired a new stake in Iqvia during the 4th quarter worth $123,000. Focused Wealth Management Inc acquired a new stake in Iqvia during the 4th quarter worth $166,000. Valeo Financial Advisors LLC acquired a new stake in Iqvia during the 4th quarter worth $170,000. IFP Advisors Inc acquired a new stake in Iqvia during the 4th quarter worth $200,000. Finally, Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in Iqvia during the 4th quarter worth $209,000. 92.34% of the stock is currently owned by institutional investors.
Several brokerages have issued reports on IQV. SunTrust Banks raised shares of Iqvia from a “hold” rating to a “buy” rating in a research note on Wednesday, March 7th. ValuEngine raised shares of Iqvia from a “hold” rating to a “buy” rating in a research note on Tuesday, February 20th. Zacks Investment Research cut shares of Iqvia from a “hold” rating to a “sell” rating in a research note on Tuesday, February 20th. Royal Bank of Canada set a $118.00 target price on shares of Iqvia and gave the stock a “buy” rating in a research note on Thursday, February 15th. Finally, Piper Jaffray Companies reaffirmed a “hold” rating and set a $103.00 target price on shares of Iqvia in a research note on Thursday, February 15th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $110.02.
Iqvia Holdings Inc (NYSE IQV) opened at $105.93 on Tuesday. Iqvia Holdings Inc has a fifty-two week low of $76.80 and a fifty-two week high of $110.67. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 1.21. The company has a market capitalization of $21,993.32, a price-to-earnings ratio of 22.91, a PEG ratio of 2.70 and a beta of 0.64.
Iqvia (NYSE:IQV) last issued its quarterly earnings data on Wednesday, February 14th. The medical research company reported $1.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.34 by ($0.02). The company had revenue of $2.16 billion during the quarter, compared to analysts’ expectations of $2.14 billion. Iqvia had a net margin of 13.44% and a return on equity of 13.03%. The firm’s quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.09 earnings per share. research analysts expect that Iqvia Holdings Inc will post 2.84 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: This report was first published by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/03/13/cornerstone-capital-management-holdings-llc-takes-position-in-iqvia-holdings-inc-iqv.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.